FibroBiologics Rings the Opening Bell

About This Event

FibroBiologics (Nasdaq: FBLG), a biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Pete O'Heeron, Chief Executive Officer, rings the Opening Bell.

 

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore